Exact Mass: 576.3563

Collettiside I

C33H52O8 (576.3662)

Diosgenin 3-O-beta-D-glucoside is a sterol 3-beta-D-glucoside having diosgenin as the sterol component. It has a role as a metabolite. It is a sterol 3-beta-D-glucoside, a monosaccharide derivative, a hexacyclic triterpenoid and a spiroketal. It is functionally related to a diosgenin. It derives from a hydride of a spirostan. Disogluside is a natural product found in Allium rotundum, Allium narcissiflorum, and other organisms with data available. Capsicoside A3 is found in herbs and spices. Capsicoside A3 is a constituent of Capsicum annuum roots. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

Oleandrin

C32H48O9 (576.3298)

Oleandrin is a steroid saponin that consists of oleandrigenin having a 2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl residue attached to the oxygen function at position 3. It is a cardenolide glycoside, a 14beta-hydroxy steroid, a steroid ester and a steroid saponin. It is functionally related to an oleandrigenin. Oleandrin has been used in trials studying the treatment of Lung Cancer and Chemotherapeutic Agent Toxicity. Oleandrin is a natural product found in Daphnis nerii, Plumeria, and other organisms with data available. Oleandrin is a lipid soluble cardiac glycoside with potential antineoplastic activity. Upon administration, oleandrin specifically binds to and inhibits the alpha3 subunit of the Na/K-ATPase pump in human cancer cells. This may inhibit the phosphorylation of Akt, upregulate MAPK, inhibit NF-kb activation and inhibit FGF-2 export and may downregulate mTOR thereby inhibiting p70S6K and S6 protein expression. All of this may lead to an induction of apoptosis. As cancer cells with relatively higher expression of the alpha3 subunit and with limited expression of the alpha1 subunit are more sensitive to oleandrin, one may predict the tumor response to treatment with lipid-soluble cardiac glycosides such as oleandrin based on the tumors Na/K-ATPase pump protein subunit expression. Overexpression of the alpha3 subunit in tumor cells correlates with tumor proliferation. See also: Nerium oleander leaf (part of). A steroid saponin that consists of oleandrigenin having a 2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl residue attached to the oxygen function at position 3. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2262 Oleandrin (PBI-05204) inhibits the Na+, K+-ATPase activity with an IC50 of 620 nM. Oleandrin (PBI-05204) inhibits the Na+, K+-ATPase activity with an IC50 of 620 nM.

Cerberin

C32H48O9 (576.3298)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides A cardenolide glycoside that is the 2-acetyl derivative of neriifolin.

Etiopurpurin

C37H44N4O2 (576.3464)

Foliandrin

C32H48O9 (576.3298)

PA(8:0/18:1(12Z)-O(9S,10R))

C29H53O9P (576.3427)

PA(8:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-O(9S,10R)/8:0)

C29H53O9P (576.3427)

PA(18:1(12Z)-O(9S,10R)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/8:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:1(9Z)-O(12,13))

C29H53O9P (576.3427)

PA(8:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(9Z)-O(12,13)/8:0)

C29H53O9P (576.3427)

PA(18:1(9Z)-O(12,13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/8:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Sanggenol E

C35H44O7 (576.3087)

MCULE-8628710105

C30H56O10 (576.3873)

Agosterol D2

C33H52O8 (576.3662)

(-)-Buxapapinolamine

C35H48N2O5 (576.3563)

Thorexanthin

C41H52O2 (576.3967)

Hippuristerone F

C33H52O8 (576.3662)

1,3-Diacetyl-24-epi-polacandrin

C34H56O7 (576.4026)

Agosterol A

C33H52O8 (576.3662)

Agosterol E

C33H52O8 (576.3662)

Agosterol G

C33H52O8 (576.3662)

3alpha-acetoxy-21S,25-dimethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin F

C34H56O7 (576.4026)

3alpha-acetoxy-21R-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S,25-triol|chisopanin G

C34H56O7 (576.4026)

23,24-dihydro-7beta-hydroxycucurbitacin B

C32H48O9 (576.3298)

SCHEMBL13641595

C38H48N4O (576.3828)

rel-18(S),19(R)-diacetoxy-18,19-epoxy-6(R)-hydroxy-2(S)-(3xi-hydroxyoctanoyloxy)-5(R),8(S),9(S),10(R)-cleroda-3,13(16),14-triene

C32H48O9 (576.3298)

Methyl-2alpha-benzoyloxy-3beta-hydroxy-urs-12-en-28-oat

C37H52O5 (576.3815)

methyl musangate B

C33H52O8 (576.3662)

14-(N,N-dimethyl-L-valyloxy)paspalinine

C34H44N2O6 (576.3199)

Venturicidin X

C34H56O7 (576.4026)

O10-Buxafuranamine

C35H48N2O5 (576.3563)

3beta-hydroxy-27-benzoyloxylup-20(29)-en-28-oic acid

C37H52O5 (576.3815)

2alpha-hydroxyzuelanin-6beta-n-(3-hydroxy)octanoate

C32H48O9 (576.3298)

Raspacionin

C34H56O7 (576.4026)

C33H52O8

C33H52O8 (576.3662)

(24R)-ergost-5-en-11-oxo-3beta-ol-alpha-D-glucopyranoside|argyroside

C34H56O7 (576.4026)

O6-Buxafuranamine

C35H48N2O5 (576.3563)

nolinospiroside C

C33H52O8 (576.3662)

C34H56O7

C34H56O7 (576.4026)

4-O-acetyl-3-O-[beta-D-arabinopyranosyloxy]-cholest-5-ene-3beta,19-diol

C34H56O7 (576.4026)

methyl 3-beta-acetoxy-2alpha,11alpha,19alpha,28-tetrahydroxyurs-12-en-24-oate

C33H52O8 (576.3662)

agladoral E

C34H56O7 (576.4026)

ypsilanogenin

C33H52O8 (576.3662)

7-hydroxy-cucurbitacin F 25-O-acetate

C32H48O9 (576.3298)

6-O-[(7Z,10Z)-hexadeca-7,10-dienoyl]-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside

C28H48O12 (576.3146)

21,24-diacetoxylanostan-3,22,25-triol|terresterol

C34H56O7 (576.4026)

C32H48O9

C32H48O9 (576.3298)

Teraspiridole D_130092

C34H44N2O6 (576.3199)

3beta-O-(alpha-L-fucopyranosyl)-11-hydroxy-24-methylene-9,11-secocholest-5-en-9-one|sinularoside A

C34H56O7 (576.4026)

(25S)-3-oxo-5alpha-spirostan-6alpha-yl-O-beta-D-xylopyranoside

C33H52O8 (576.3662)

30-(4-hydroxybenzoyloxy)-11alpha-hydroxylupane-20(29)-en-3-one

C37H52O5 (576.3815)

cimicifugoside H-4|foetidinol-3-O-beta-D-xylopyranoside|foetidinol-3-O-beta-xyloside|neocimiside

C32H48O9 (576.3298)

ruscogenin 3-O-alpha-L-rhamnopyranoside

C33H52O8 (576.3662)

24-methylenecholest-5-en-3beta,7beta,16beta-triol-3-O-alpha-L-fucoside|24-methylenecholest-5-ene-3beta,7beta,16beta-triol-3-O-alpha-L-fucopyranoside

C34H56O7 (576.4026)

Phomenolactone

C34H56O7 (576.4026)

cholest-8-ene-3beta,5alpha,6alpha,7alpha,10alpha-pentol 3,6,7-triacetate

C33H52O8 (576.3662)

(25S)-6alpha-hydroxy-5alpha-spirostan-3-one 6-O-(beta-D-quinovopyranoside)|solagenin 6-O-(beta-D-quinovopyranoside)

C33H52O8 (576.3662)

methyl musangate A

C33H52O8 (576.3662)

agosterol C6

C33H52O8 (576.3662)

cimicifugoside H-3

C32H48O9 (576.3298)

Lys Glu Ser Leu Ser

C24H44N6O10 (576.3119)

Phe Val Arg Arg

C26H44N10O5 (576.3496)

Phe Lys Leu Arg

C28H48N8O5 (576.3747)

Ile Gly Lys Ile Phe

C29H48N6O6 (576.3635)

5-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-3-hydroxydecanoic acid

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid

C30H56O10 (576.3873)

C32H48O9_beta-D-Xylopyranoside, 3,17-dihydroxyspirosta-5,25(27)-dien-1-yl

C32H48O9 (576.3298)

C32H48O9_Card-20(22)-enolide, 16-(acetyloxy)-3-[(2,6-dideoxy-3-O-methylhexopyranosyl)oxy]-14-hydroxy-, (3beta,5beta,8xi,9xi,16beta)

C32H48O9 (576.3298)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid [IIN-based on: CCMSLIB00000848124]

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid [IIN-based: Match]

C30H56O10 (576.3873)

Phe Arg Arg Val

C26H44N10O5 (576.3496)

Phe Arg Val Arg

C26H44N10O5 (576.3496)

His His Lys Arg

C24H40N12O5 (576.3244)

His His Arg Lys

C24H40N12O5 (576.3244)

His Lys His Arg

C24H40N12O5 (576.3244)

His Lys Arg His

C24H40N12O5 (576.3244)

His Arg His Lys

C24H40N12O5 (576.3244)

His Arg Lys His

C24H40N12O5 (576.3244)

Ile Lys Met Trp

C28H44N6O5S (576.3094)

Ile Lys Trp Met

C28H44N6O5S (576.3094)

Ile Met Lys Trp

C28H44N6O5S (576.3094)

Ile Met Trp Lys

C28H44N6O5S (576.3094)

Ile Trp Lys Met

C28H44N6O5S (576.3094)

Ile Trp Met Lys

C28H44N6O5S (576.3094)

Lys His His Arg

C24H40N12O5 (576.3244)

Lys His Arg His

C24H40N12O5 (576.3244)

Lys Ile Met Trp

C28H44N6O5S (576.3094)

Lys Ile Trp Met

C28H44N6O5S (576.3094)

Lys Leu Met Trp

C28H44N6O5S (576.3094)

Lys Leu Trp Met

C28H44N6O5S (576.3094)

Lys Met Ile Trp

C28H44N6O5S (576.3094)

Lys Met Leu Trp

C28H44N6O5S (576.3094)

Lys Met Trp Ile

C28H44N6O5S (576.3094)

Lys Met Trp Leu

C28H44N6O5S (576.3094)

Lys Arg His His

C24H40N12O5 (576.3244)

Lys Trp Ile Met

C28H44N6O5S (576.3094)

Lys Trp Leu Met

C28H44N6O5S (576.3094)

Lys Trp Met Ile

C28H44N6O5S (576.3094)

Lys Trp Met Leu

C28H44N6O5S (576.3094)

Leu Lys Met Trp

C28H44N6O5S (576.3094)

Leu Lys Trp Met

C28H44N6O5S (576.3094)

Leu Met Lys Trp

C28H44N6O5S (576.3094)

Leu Met Trp Lys

C28H44N6O5S (576.3094)

Leu Trp Lys Met

C28H44N6O5S (576.3094)

Leu Trp Met Lys

C28H44N6O5S (576.3094)

Met Ile Lys Trp

C28H44N6O5S (576.3094)

Met Ile Trp Lys

C28H44N6O5S (576.3094)

Met Lys Ile Trp

C28H44N6O5S (576.3094)

Met Lys Leu Trp

C28H44N6O5S (576.3094)

Met Lys Trp Ile

C28H44N6O5S (576.3094)

Met Lys Trp Leu

C28H44N6O5S (576.3094)

Met Leu Lys Trp

C28H44N6O5S (576.3094)

Met Leu Trp Lys

C28H44N6O5S (576.3094)

Met Trp Ile Lys

C28H44N6O5S (576.3094)

Met Trp Lys Ile

C28H44N6O5S (576.3094)

Met Trp Lys Leu

C28H44N6O5S (576.3094)

Met Trp Leu Lys

C28H44N6O5S (576.3094)

Arg Phe Arg Val

C26H44N10O5 (576.3496)

Arg Phe Val Arg

C26H44N10O5 (576.3496)

Arg His His Lys

C24H40N12O5 (576.3244)

Arg His Lys His

C24H40N12O5 (576.3244)

Arg Lys His His

C24H40N12O5 (576.3244)

Arg Arg Phe Val

C26H44N10O5 (576.3496)

Arg Arg Val Phe

C26H44N10O5 (576.3496)

Arg Val Phe Arg

C26H44N10O5 (576.3496)

Arg Val Arg Phe

C26H44N10O5 (576.3496)

Val Phe Arg Arg

C26H44N10O5 (576.3496)

Val Arg Phe Arg

C26H44N10O5 (576.3496)

Val Arg Arg Phe

C26H44N10O5 (576.3496)

Trp Ile Lys Met

C28H44N6O5S (576.3094)

Trp Ile Met Lys

C28H44N6O5S (576.3094)

Trp Lys Ile Met

C28H44N6O5S (576.3094)

Trp Lys Leu Met

C28H44N6O5S (576.3094)

Trp Lys Met Ile

C28H44N6O5S (576.3094)

Trp Lys Met Leu

C28H44N6O5S (576.3094)

Trp Leu Lys Met

C28H44N6O5S (576.3094)

Trp Leu Met Lys

C28H44N6O5S (576.3094)

Trp Met Ile Lys

C28H44N6O5S (576.3094)

Trp Met Lys Ile

C28H44N6O5S (576.3094)

Trp Met Lys Leu

C28H44N6O5S (576.3094)

Trp Met Leu Lys

C28H44N6O5S (576.3094)

IGKIF

C29H48N6O6 (576.3635)

KESTL

C24H44N6O10 (576.3119)

1-Hydroxyvitamin D3 3-D-glucopyranoside

C33H52O8 (576.3662)

D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

PA(12:0/15:1(9Z))

C30H57O8P (576.3791)

PA(13:0/14:1(9Z))

C30H57O8P (576.3791)

PA(14:1(9Z)/13:0)

C30H57O8P (576.3791)

PA(15:1(9Z)/12:0)

C30H57O8P (576.3791)

Exophilin A1

C30H56O10 (576.3873)

PA 27:1

C30H57O8P (576.3791)

OHOHA-PA

C28H49O10P (576.3063)

Superecdysone E

C33H52O8 (576.3662)

3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloart-7-en-23-one-3-O-beta-D-xylopyranoside

C32H48O9 (576.3298)

ST 27:2;O2;GlcA

C33H52O8 (576.3662)

Bisdehydro-beta-carotene-2-carboxylic acid

C41H52O2 (576.3967)

Clathriaxanthin

C41H52O2 (576.3967)

di-n-butyl dineodecanoate tin

C28H56O4Sn (576.32)

Aluminum,tris(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (OC-6-11)-

C33H57AlO6 (576.397)

N,N-dimethyl-4-[2-(1-octadecylpyridin-1-ium-2-yl)ethenyl]aniline,perchlorate

C33H53ClN2O4 (576.3694)

2,2-bis[4,4-cyclohexylidenebis(4-hydroxyphenyl)]propane

C39H44O4 (576.3239)

methyl 1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-L-prolyl-beta-phenyl-L-phenylalaninate

C33H44N4O5 (576.3312)

Collettiside I

C33H52O8 (576.3662)

Constituent of Trigonella foenum-graecum (fenugreek). Collettiside I is found in herbs and spices and fenugreek. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

3-Hydroxy-5-(3-hydroxy-5-(3,5-dihydroxydecanoyloxy)decanoyloxy)decanoic acid

C30H56O10 (576.3873)

(6R)-6-[(1R,3aS,4E,7aR)-4-{(2Z)-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyloctahydro-1H-inden-1-yl]-2-methylheptan-2-yl beta-D-glucopyranosiduronic acid

C33H52O8 (576.3662)

2,3-O-methyl-rhamnosyl tetracyclic spinosyn pseudoaglycone

C32H48O9 (576.3298)

solasodine 3-O-beta-D-glucopyranoside

C33H54NO7+ (576.39)

Solasodine galactoside

C33H54NO7+ (576.39)

3-O-beta-D-glucosyl-diosgenin

C33H52O8 (576.3662)

23,24-dihydrocucurbitacin A

C32H48O9 (576.3298)

3-[(21S,22S)-16-ethenyl-26-ethyl-4-hydroxy-12,17,21-trimethyl-11-(2-methylpropyl)-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C36H40N4O3 (576.31)

Etiopurpurin

C37H44N4O2 (576.3464)

PA(8:0/18:1(12Z)-O(9S,10R))

C29H53O9P (576.3427)

PA(18:1(12Z)-O(9S,10R)/8:0)

C29H53O9P (576.3427)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C29H53O9P (576.3427)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C29H53O9P (576.3427)

2-(Hydroxymethyl)-6-(5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2-piperidin-1-ium]-16-yl)oxyoxane-3,4,5-triol

C33H54NO7+ (576.39)

2-[[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[(2R)-3-acetyloxy-2-[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-2-acetyloxy-3-[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-3-acetyloxy-2-[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-2-acetyloxy-3-[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-3-acetyloxy-2-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-2-acetyloxy-3-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-3-acetyloxy-2-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

2-[[(2R)-2-acetyloxy-3-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H51NO9P+ (576.3301)

3-ethyl-2-methoxy-5-methyl-6-[(1E,5E,7E,11E)-3,7,9,11-tetramethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytrideca-1,5,7,11-tetraenyl]pyran-4-one

C32H48O9 (576.3298)

(+)-Buxafuranamide

C35H48N2O5 (576.3563)

A natural product found in Buxus natalensis.

solasodine 3-beta-D-glucoside

C33H54NO7+ (576.39)

1-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

1-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C33H44N4O5 (576.3312)

3-[5-(3,5-Dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid

C30H56O10 (576.3873)

[(3R)-2-tert-butylsulfinyl-4-[3-(3-cyclopentylprop-1-ynyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-methyl-1-piperazinyl)methanone

C33H44N4O3S (576.3134)

[(3S)-2-tert-butylsulfinyl-4-[3-(3-cyclopentylprop-1-ynyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-methyl-1-piperazinyl)methanone

C33H44N4O3S (576.3134)

NAGlySer 16:4/11:0

C32H52N2O7 (576.3774)

2,3-dihydroxypropyl [2-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] hydrogen phosphate

C30H57O8P (576.3791)

PE-Cer 15:1;2O/12:1;O

C29H57N2O7P (576.3903)

PE-Cer 14:2;2O/13:0;O

C29H57N2O7P (576.3903)

PE-Cer 15:2;2O/12:0;O

C29H57N2O7P (576.3903)

PE-Cer 12:2;2O/15:0;O

C29H57N2O7P (576.3903)

PE-Cer 12:1;2O/15:1;O

C29H57N2O7P (576.3903)

PE-Cer 14:1;2O/13:1;O

C29H57N2O7P (576.3903)

PE-Cer 13:1;2O/14:1;O

C29H57N2O7P (576.3903)

PE-Cer 13:2;2O/14:0;O

C29H57N2O7P (576.3903)

PEtOH 25:1

C30H57O8P (576.3791)

PMeOH 13:0_13:1

C30H57O8P (576.3791)

PMeOH 12:0_14:1

C30H57O8P (576.3791)

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C30H56O10 (576.3873)

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate

C30H56O10 (576.3873)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

C30H56O10 (576.3873)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

C30H56O10 (576.3873)

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate

C30H56O10 (576.3873)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

C30H56O10 (576.3873)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C30H56O10 (576.3873)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate

C30H56O10 (576.3873)

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate

C30H56O10 (576.3873)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C28H49O10P (576.3063)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C28H49O10P (576.3063)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C28H49O10P (576.3063)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

C30H57O8P (576.3791)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

C30H57O8P (576.3791)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C28H49O10P (576.3063)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate

C30H57O8P (576.3791)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C28H49O10P (576.3063)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate

C30H57O8P (576.3791)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C28H49O10P (576.3063)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-tetracos-13-enoate

C30H57O8P (576.3791)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-tetradec-9-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-hexadec-9-enoate

C30H57O8P (576.3791)

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetradecanoate

C30H57O8P (576.3791)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-pentadec-9-enoate

C30H57O8P (576.3791)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

C30H57O8P (576.3791)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H52O5 (576.3815)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-hexadec-7-enoate

C30H57O8P (576.3791)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C30H57O8P (576.3791)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-pentadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-pentadec-9-enoate

C30H57O8P (576.3791)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-hexadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

C30H57O8P (576.3791)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] undecanoate

C30H56O10 (576.3873)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-tetradec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C30H57O8P (576.3791)

2-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate

C30H56O10 (576.3873)

2-[[3-acetyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[2-butanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[1-carboxy-3-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C33H54NO7+ (576.39)

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[3-butanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H55NO8P+ (576.3665)

2-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C33H54NO7+ (576.39)

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[2-acetyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

Trillin

C33H52O8 (576.3662)

Diosgenin 3-O-beta-D-glucoside is a sterol 3-beta-D-glucoside having diosgenin as the sterol component. It has a role as a metabolite. It is a sterol 3-beta-D-glucoside, a monosaccharide derivative, a hexacyclic triterpenoid and a spiroketal. It is functionally related to a diosgenin. It derives from a hydride of a spirostan. Disogluside is a natural product found in Allium rotundum, Allium narcissiflorum, and other organisms with data available. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent A sterol 3-beta-D-glucoside having diosgenin as the sterol component. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

PM060431

C32H48O9 (576.3298)

A natural product found in Streptomyces albus.

calcidiol 3-O-(beta-D-glucuronide)

C33H52O8 (576.3662)

A steroid glucosiduronic acid that is calcidiol in which the hydroxy hydrogen at position 3 has been replaced by a beta-D-glucuronyl residue.

1-dodecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C30H57O8P (576.3791)

1-tridecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C30H57O8P (576.3791)

1-(9Z-tetradecenoyl)-2-tridecanoyl-glycero-3-phosphate

C30H57O8P (576.3791)

1-(9Z-pentadecenoyl)-2-dodecanoyl-glycero-3-phosphate

C30H57O8P (576.3791)

calcidiol 25-O-(beta-D-glucuronide)

C33H52O8 (576.3662)

A steroid glucosiduronic acid that is calcidiol in which the hydroxy hydrogen at position 25 has been replaced by a beta-D-glucuronyl residue.

MGDG 10:0_11:0

C30H56O10 (576.3873)

MGDG 21:0

C30H56O10 (576.3873)

MGDG O-21:1;O

C30H56O10 (576.3873)

DGGA 20:0

C29H52O11 (576.3509)

MGGA 21:0

C30H56O10 (576.3873)

PA O-16:0/11:2;O

C30H57O8P (576.3791)

PA O-18:0/8:3;O2

C29H53O9P (576.3427)

PA O-25:4;O3

C28H49O10P (576.3063)

PA O-26:3;O2

C29H53O9P (576.3427)

PA O-27:2;O

C30H57O8P (576.3791)

PA P-18:0/7:3;O3

C28H49O10P (576.3063)

PA P-18:0/8:2;O2

C29H53O9P (576.3427)

PA P-18:0/9:1;O

C30H57O8P (576.3791)

PA P-18:1/7:2;O3

C28H49O10P (576.3063)

PA P-18:1/8:1;O2

C29H53O9P (576.3427)

PA 18:0/7:3;O2

C28H49O10P (576.3063)

PA 18:1/7:2;O2

C28H49O10P (576.3063)

PA 18:1/8:1;O

C29H53O9P (576.3427)

PA 20:0/6:2;O

C29H53O9P (576.3427)

PA 20:2/5:1;O2

C28H49O10P (576.3063)

PA 22:1/4:1;O

C29H53O9P (576.3427)

PA 26:2;O

C29H53O9P (576.3427)

PA 10:0_17:1

C30H57O8P (576.3791)

PA 11:0_16:1

C30H57O8P (576.3791)

PA 12:0_15:1

C30H57O8P (576.3791)

PA 13:0_14:1

C30H57O8P (576.3791)

PA 23:0/4:1

C30H57O8P (576.3791)

PG O-22:4;O

C28H49O10P (576.3063)

PG P-16:1/6:2;O

C28H49O10P (576.3063)

PG P-18:1/4:2;O

C28H49O10P (576.3063)

LPG 22:4;O

C28H49O10P (576.3063)

PG 18:2/4:1

C28H49O10P (576.3063)

PG 18:3/4:0

C28H49O10P (576.3063)

PG 2:0_20:3

C28H49O10P (576.3063)

PG 20:3/2:0

C28H49O10P (576.3063)

PG 22:3

C28H49O10P (576.3063)

PEth 24:2;O

C29H53O9P (576.3427)

PEth 25:1

C30H57O8P (576.3791)

PM 25:2;O

C29H53O9P (576.3427)

PM 26:1

C30H57O8P (576.3791)

CerPE 14:2;O2/13:0;O

C29H57N2O7P (576.3903)

CerPE 15:2;O2/12:0;O

C29H57N2O7P (576.3903)

CerPE 16:2;O2/11:0;O

C29H57N2O7P (576.3903)

CerPE 17:2;O2/10:0;O

C29H57N2O7P (576.3903)

CerPE 27:2;O2;O

C29H57N2O7P (576.3903)

SM 14:2;O2/10:0;O

C29H57N2O7P (576.3903)

SM 24:2;O2;O

C29H57N2O7P (576.3903)

Hydroxyvitamin D3 glucoside

C33H52O8 (576.3662)

ST 26:3;O3;GlcA

C32H48O9 (576.3298)

ST 28:1;O;GlcA

C34H56O7 (576.4026)

ST 22:0;O7;Hex

C28H48O12 (576.3146)

ST 26:4;O4;Hex

C32H48O9 (576.3298)

ST 27:3;O3;Hex

C33H52O8 (576.3662)

ST 28:2;O2;Hex

C34H56O7 (576.4026)

ST 29:0;O6;S

C29H52O9S (576.3332)

(4r,6r)-4-hydroxy-6-[(1e,4r,5e,8r,9e,11s,12r,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-[(2r,4s,6s)-2,4,6-trimethyloctylidene]hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

(1r,3r,5s,6ar,7r,8s,10s,10ar)-1,3-bis(acetyloxy)-5-hydroxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (3s)-3-hydroxyoctanoate

C32H48O9 (576.3298)

7-(acetyloxy)-11-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4026)

4-hydroxy-6-[(1e,5e,9e,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

(2r,3r)-2-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C35H44O7 (576.3087)

n-[(1s,3r,4s,6r,7s,8r,13s,16s,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,14-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(1s,6r,7s,8r,10s,11r,13s,14r,15s,16s)-8-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

(2s)-2,4,6,9-tetrahydroxy-2-[(2e,6e,10z)-12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5,7-dimethylphenalene-1,3-dione

C35H44O7 (576.3087)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

18-hydroxy-15-(5-hydroxy-4-oxopentan-2-yl)-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C32H48O9 (576.3298)

n-[6-(acetyloxy)-7-[1-(dimethylamino)ethyl]-15-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,13-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

2-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C35H44O7 (576.3087)

1-{11a-[(acetyloxy)methyl]-2-hydroxy-3',9a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

(6r)-6-methoxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C41H52O2 (576.3967)

8-(acetyloxy)-3,21-dihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H48O9 (576.3298)

1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 3-hydroxyoctanoate

C32H48O9 (576.3298)

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-10-(acetyloxy)-3,9-dibutoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl acetate

C33H52O8 (576.3662)

2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n,4-dimethylpentanamido}-1-hydroxy-4-methylpentylidene)amino]-3-methylbutanoic acid

C28H53ClN4O6 (576.3653)

methyl 3-(acetyloxy)-2,12,14-trihydroxy-8a-(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylate

C33H52O8 (576.3662)

beauwalloside

C32H48O9 (576.3298)

{"Ingredient_id": "HBIN017673","Ingredient_name": "beauwalloside","Alias": "NA","Ingredient_formula": "C32H48O9","Ingredient_Smile": "CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O","Ingredient_weight": "576.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2190","TCMSP_id": "NA","TCM_ID_id": "6409;21740","PubChem_id": "56841099","DrugBank_id": "NA"}

(2s,3s)-2-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C35H44O7 (576.3087)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy}oxane-3,4,5-triol

C33H52O8 (576.3662)

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

methyl (1r,2s,4ar,4bs,5s,6as,9r,10r,10as,12as)-5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

6-{[3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-2-methyloxan-3-yl acetate

C32H48O9 (576.3298)

(1s,4r,5s,16r,18s,19s,23r)-19-hydroxy-4,5,24,24-tetramethyl-22-oxo-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-18-yl (2s)-2-(dimethylamino)-3-methylbutanoate

C34H44N2O6 (576.3199)

methyl (1r,2s,4ar,4bs,6as,7s,9r,10r,10as,12ar)-7,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

(2s,3s,4r,5s,6s)-2-{[(1s,3as,3br,5as,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H48O9 (576.3298)

6-{[9a-(hydroxymethyl)-11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4026)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-10-(acetyloxy)-1,9-dibutoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12'r,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4e,6e,9z)-3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C33H52O8 (576.3662)

[7-(acetyloxy)-8,9-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4026)

6-hydroxy-2-methyl-5-oxo-6-{2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl}heptan-2-yl acetate

C32H48O9 (576.3298)

4-hydroxy-6-[4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

cimicifugoside h-4

C32H48O9 (576.3298)

(1r,2s,3as,3br,5as,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4r,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

4'-epioleandrin

C32H48O9 (576.3298)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4r,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(3r,5ar,6r,7s,9ar)-6-{2-[(3r,5ar,6s,9ar)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(3r,5r)-3-{[(3r,5r)-5-{[(3r,5r)-3,5-dihydroxydecanoyl]oxy}-3-hydroxydecanoyl]oxy}-5-hydroxydecanoic acid

C30H56O10 (576.3873)

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-11a-[(acetyloxy)methyl]-2-hydroxy-3',9a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

C33H52O8 (576.3662)

(3r,5r,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-(acetyloxy)-2,5-dihydroxy-2-methylheptan-3-yl acetate

C34H56O7 (576.4026)

(3s,5as,6s,7r,9as)-6-{2-[(3s,5as,6r,9as)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(2s,3s,4s,5s,6s)-2-{[(1r,3as,3bs,5ar,7s,9as,9br,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H48O9 (576.3298)

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

n-[8-(acetyloxy)-7-[1-(dimethylamino)ethyl]-13-hydroxy-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(6s,7r,8r,9s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7-formyl-9-hydroxy-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(1r,3r,4s,6r,7s,8r,13s,16s,17r,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,14-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4026)

3-ethyl-2-methoxy-5-methyl-6-[(1e,5e,7e,11e)-3,7,9,11-tetramethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}trideca-1,5,7,11-tetraen-1-yl]pyran-4-one

C32H48O9 (576.3298)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2s,2'r,4'r,5s,7'r,8's,9's,12's,13'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

4-hydroxy-1-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9br,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H48O9 (576.3298)

6-methoxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C41H52O2 (576.3967)

5-({5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl}oxy)-3-hydroxydecanoic acid

C30H56O10 (576.3873)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(6r)-6-[(1r,2r,3as,3bs,4s,8s,9ar,9bs,11ar)-2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C32H48O9 (576.3298)

2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-10''-yl acetate

C34H44N2O6 (576.3199)

(2r,3r,4s,5r,6r)-2-methyl-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

methyl (2r,3r,4s,4ar,6ar,6bs,8as,11r,12r,12as,14r,14ar,14bs)-3-(acetyloxy)-2,12,14-trihydroxy-8a-(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylate

C33H52O8 (576.3662)

[(1r,3ar,3br,5ar,6r,7r,8r,9r,9ar,9bs,11ar)-7-(acetyloxy)-8,9-dihydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

methyl 5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-(3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl)pyran-2-one

C33H52O8 (576.3662)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

3-(acetyloxy)-6-[2-(3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-7-(acetyloxy)-11-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4026)

methyl 7,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

C36H48O6 (576.3451)

(1''r,2''r,8''r,9's,9'as,10''s,11''r,12''s,16''s)-2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-10''-yl acetate

C34H44N2O6 (576.3199)

(1s,3r,5r,6as,7r,8r,10s,10as)-1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (3s)-3-hydroxyoctanoate

C32H48O9 (576.3298)

(1r,3s,4s,4's,5s,7r,8s,10s,13s,14s,16s,18s,19r,21r,22r)-8-(acetyloxy)-3,21-dihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H48O9 (576.3298)

(1's,2s,5s,6r,10'z,12'z,14's,15's,16'z,19'r)-6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

C36H48O6 (576.3451)

19-hydroxy-4,5,24,24-tetramethyl-22-oxo-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-18-yl 2-(dimethylamino)-3-methylbutanoate

C34H44N2O6 (576.3199)

(3e,5e,11e,13e)-16-[4-(6-ethyl-2-hydroxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C34H56O7 (576.4026)

12-ethyl-6-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-3-ol

C38H48N4O (576.3828)

2,4,6,9-tetrahydroxy-2-[12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5,7-dimethylphenalene-1,3-dione

C35H44O7 (576.3087)

(1r,9r,12r,19r)-12-ethyl-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-3-ol

C38H48N4O (576.3828)

(1r,2r,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

7-(acetyloxy)-2,5-dihydroxy-6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate

C34H56O7 (576.4026)

n-[(1s,3r,4s,6r,7s,8r,15r,16r,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-15-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,13-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

2-methyl-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}oxane-3,4,5-triol

C33H52O8 (576.3662)

(3r,4s,5s,6s)-6-{[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4026)

(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-5a-[(benzoyloxy)methyl]-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C37H52O5 (576.3815)

(3r,5r)-5-{[(3r,5r)-5-{[(3r,5r)-3,5-dihydroxydecanoyl]oxy}-3-hydroxydecanoyl]oxy}-3-hydroxydecanoic acid

C30H56O10 (576.3873)

3-ethyl-2-methoxy-5-methyl-6-[(1e,5e,7e,11e)-3,7,9,11-tetramethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}trideca-1,5,7,11-tetraen-1-yl]pyran-4-one

C32H48O9 (576.3298)

1,3-bis(acetyloxy)-5-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 3-hydroxyoctanoate

C32H48O9 (576.3298)

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H48O9 (576.3298)

2,9,10-trihydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-13-en-8-one

C32H48O9 (576.3298)

5a-[(benzoyloxy)methyl]-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C37H52O5 (576.3815)